# EOM Pharmaceutical Holdings, Inc.

EOM Pharmaceutical Holdings, Inc. is a company headquartered in Westlake Village, CA, United States.

## Company overview

- **Legal name:** EOM Pharmaceutical Holdings, Inc.
- **Former names in filing history:** ImmunoCellular Therapeutics, Ltd. (2006-10-23 to 2022-09-12); Optical Molecular Imaging, Inc (2006-02-06 to 2006-09-20); PATCO INDUSTRIES LTD (1999-11-24 to 2006-01-26)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Westlake Village, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000822411

## About

EOM Pharmaceutical Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000822411, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-03-14, it reported annual revenue of USD 0; net income of USD -14,312,007; total assets of USD 7,009,225 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$14.3M (USD -14,312,007)
- **Total assets:** $7.0M (USD 7,009,225)
- **Cash and equivalents:** $6.6M (USD 6,629,870)
- **Operating cash flow:** -$16.7M (USD -16,671,777)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$22.1M (USD -22,085,702)
- **Total assets:** $16.9M (USD 16,889,990)
- **Cash and equivalents:** $11.4M (USD 11,437,118)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$12.8M (USD -12,790,814)
- **Total assets:** $30.1M (USD 30,082,374)
- **Cash and equivalents:** $22.6M (USD 22,604,481)

### FY2014 (period ended 2014-12-31)

- **Net income:** -$9.4M (USD -9,377,533)
- **Total assets:** $25.2M (USD 25,178,561)
- **Cash and equivalents:** $23.2M (USD 23,222,296)

## Recent SEC filings

- Form S-1 — filed 2022-06-24
- Form 8-K — filed 2018-10-17 — period 2018-10-16 — 8-K
- Form 8-K — filed 2018-10-15 — period 2018-10-10 — FORM 8-K
- Form 8-K — filed 2018-08-16 — period 2018-08-13 — 8-K
- Form 10-Q — filed 2018-08-13 — period 2018-06-30 — 10-Q
- Form 8-K — filed 2018-05-15 — period 2018-05-14 — FORM 8-K
- Form 10-Q — filed 2018-05-14 — period 2018-03-31 — 10-Q
- Form 10-K — filed 2018-03-14 — period 2017-12-31 — 10-K
- Form 8-K — filed 2018-03-13 — period 2018-03-13 — 8-K
- Form 8-K — filed 2018-02-13 — period 2018-02-13 — 8-K
- Form 8-K — filed 2018-02-02 — period 2018-01-29 — 8-K
- Form 8-K — filed 2017-11-21 — period 2017-11-21 — FORM 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/eom-pharmaceutical-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology